BALTIMORE, Sept. 10 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company whose personalized oncology services division assists physicians by providing personalized treatment options for their cancer patients, has entered into a collaboration agreement with PinnacleCare, the pioneer and the leading private health advisory company in the world.
PinnacleCare will offer Champions' personalized oncology services to its members worldwide who have been diagnosed with cancer. Access to Champions' services will benefit PinnacleCare members, and their physicians, in evaluating personalized options to improve treatment outcomes. Champions' services offered to PinnacleCare members will include:
(i) Personalized Oncology Panels(TM) comprised of world-renowned experts assembled to assist the client's physician in determining the optimal treatment, and
(ii) Personalized Tumorgrafts(TM) developed from fragments of the client's living tumor that are surgically removed, propagated and tested to evaluate the effectiveness of potential treatment drugs.
Through this collaboration, Champions will also offer PinnacleCare's health advisory services to Champions clients. These services include:
(i) A PinnacleCare health advisor available globally and 24/7 answering client questions, coordinating healthcare schedules, explaining options, arranging treatments, assisting with individual medical experts, staff, and bureaucracies, and available to attend important appointments, and
(ii) PinnacleCare Electronic Health Records including collection, organization, and physician review of client medical records, with all records kept up-to-date a
|SOURCE Champions Biotechnology, Inc.|
Copyright©2009 PR Newswire.
All rights reserved